Provided By GlobeNewswire
Last update: Mar 19, 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) (HKEX:13; Nasdaq/AIM:HCM) today reports its financial results for the year ended December 31, 2024 and provides updates on key clinical and commercial developments.
Read more at globenewswire.comNASDAQ:HCM (8/20/2025, 12:21:50 PM)
15.86
-0.35 (-2.16%)
Find more stocks in the Stock Screener